Skip to content

Clinical trials

Active, not recruiting Observational Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Status: Active, not recruiting Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20112
20122
20141
20161
20173
20182
20193
20209
20216
20227
202312
20248
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting66

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Memorial Sloan Kettering Cancer Center3
Abramson Cancer Center at Penn Medicine2
M.D. Anderson Cancer Center2
Maastricht Radiation Oncology2
University College, London2
Vanderbilt-Ingram Cancer Center2
Academia Sinica, Taiwan1
Addario Lung Cancer Medical Institute1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms66
Carcinoma, Non-Small-Cell Lung22
Neoplasms8
Breast Neoplasms4
Disease4
Colorectal Neoplasms3
Head and Neck Neoplasms3
Lung Diseases3
Melanoma3
Neoplasms by Site3

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.